RITA, another p53-Reactivating small molecule, directly disrupts the interaction between p53 and MDM2 and presents a potent anti-tumor impact on HNSCC, and enhances the sensitivity of cisplatin in HNSCC cells 128. Here, MDM2 is linked to head and neck squamous cell carcinoma.